The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results